{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:05:26Z","timestamp":1772525126649,"version":"3.50.1"},"reference-count":46,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,2,27]],"date-time":"2008-02-27T00:00:00Z","timestamp":1204070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:p>\n                    <jats:bold>OBJECTIVES:<\/jats:bold>\n                    To assess the association between total insulinlike growth factor (IGF)\u20101, IGF binding protein\u20101 (IGFBP\u20101), and IGFBP\u20103 levels and functioning and mortality in older adults.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>DESIGN:<\/jats:bold>\n                    Cohort study.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>SETTING\/PARTICIPANTS:<\/jats:bold>\n                    One thousand one hundred twenty\u2010two individuals aged 65 and older without prior cardiovascular disease events participating in the Cardiovascular Health Study.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>MEASUREMENTS:<\/jats:bold>\n                    Baseline fasting plasma levels of IGF\u20101, IGFBP\u20101, and IGFBP\u20103 (defined as tertiles, T1\u2010T3) were examined in relationship to handgrip strength, time to walk 15 feet, development of new difficulties with activities of daily living (ADLs), and mortality.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    Higher IGFBP\u20101 predicted worse handgrip strength (\n                    <jats:italic>P<\/jats:italic>\n                    \u2010trend\n                    <jats:sub>T1\u2010T3<\/jats:sub>\n                    &lt;.01) and slower walking speed (\n                    <jats:italic>P<\/jats:italic>\n                    \u2010trend\n                    <jats:sub>T1\u2010T3<\/jats:sub>\n                    =.03), lower IGF\u20101 had a borderline significant association with worse handgrip strength (\n                    <jats:italic>P<\/jats:italic>\n                    \u2010trend\n                    <jats:sub>T1\u2010T3<\/jats:sub>\n                    =.06), and better grip strength was observed in the middle IGFBP\u20103 tertile than in the low or high tertiles (\n                    <jats:italic>P<\/jats:italic>\n                    =.03). Adjusted for age, sex, and race, high IGFBP\u20101 predicted greater mortality (\n                    <jats:italic>P<\/jats:italic>\n                    \u2010trend\n                    <jats:sub>T1\u2010T3<\/jats:sub>\n                    &lt;.001, hazard ratio (HR)\n                    <jats:sub>T3vsT1<\/jats:sub>\n                    =1.48, 95% confidence interval (CI)=1.15\u20131.90); this association was borderline significant after additional confounder adjustment (\n                    <jats:italic>P<\/jats:italic>\n                    \u2010trend\n                    <jats:sub>T1\u2010T3<\/jats:sub>\n                    =.05, HR\n                    <jats:sub>T3vsT1<\/jats:sub>\n                    =1.35, 95% CI=0.98\u20131.87). High IGFBP\u20101 was associated with greater risk of incident ADL difficulties after adjustment for age, sex, race, and other confounders (\n                    <jats:italic>P<\/jats:italic>\n                    \u2010trend\n                    <jats:sub>T1\u2010T3<\/jats:sub>\n                    =.04, HR\n                    <jats:sub>T3vsT1<\/jats:sub>\n                    =1.40, CI=1.01\u20131.94). Neither IGF\u20101 nor IGFBP\u20103 level predicted mortality or incident ADL difficulties.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    In adults aged 65 and older, high IGFBP\u20101 levels were associated with greater risk of mortality and poorer functional ability, whereas IGF\u20101 and IGFBP\u20103 had little association with these outcomes.\n                  <\/jats:p>","DOI":"10.1111\/j.1532-5415.2007.01637.x","type":"journal-article","created":{"date-parts":[[2008,2,27]],"date-time":"2008-02-27T13:11:23Z","timestamp":1204117883000},"page":"652-660","source":"Crossref","is-referenced-by-count":44,"title":["Total Insulinlike Growth Factor 1 and Insulinlike Growth Factor Binding Protein Levels, Functional Status, and Mortality in Older Adults"],"prefix":"10.1111","volume":"56","author":[{"given":"Robert C.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen P.","family":"McGinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael N.","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis","family":"Kuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard D.","family":"Strickler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Rohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoNan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Kritchevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne B.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce M.","family":"Psaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,2,27]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1342","article-title":"Evolutionary medicine","volume":"299","author":"Longo VD","year":"2003","journal-title":"From dwarf model systems to healthy centenarians?"},{"key":"e_1_2_6_3_2","first-page":"107","article-title":"daf\u20102, an insulin receptor\u2010like gene that regulates longevity and diapause in Caenorhabditis elegans [comment]","volume":"292","author":"Kimura KD.","year":"2001","journal-title":"Science"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.111158898"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020472"},{"key":"e_1_2_6_6_2","first-page":"163","article-title":"Insulin\u2010like growth factor binding protein\u20103 mediates tumor necrosis factor\u2010alpha\u2010induced apoptosis","volume":"13","author":"Rajah R","year":"2002","journal-title":"Role of Bcl-2 phosphorylation"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-129-4-2254"},{"key":"e_1_2_6_8_2","first-page":"319","article-title":"Insulin\u2010like growth factor binding protein\u20101","volume":"216","author":"Lee PD","year":"1997","journal-title":"Recent findings and new directions"},{"key":"e_1_2_6_9_2","first-page":"381","article-title":"Effect of recombinant IGF binding protein\u20101 on primary cultures of human keratinocytes and fibroblasts","volume":"202","author":"Kratz G","year":"1992","journal-title":"Selective enhancement of IGF-1 but not IGF-2-induced cell proliferation"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041450118"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-825730"},{"key":"e_1_2_6_12_2","first-page":"R1204","article-title":"Regulation of insulin\u2010like growth factor\u2010I (IGF\u2010I) and IGF\u2010binding proteins by tumor necrosis factor","volume":"269","author":"Fan J","year":"1995","journal-title":"Am J Physiol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.1705"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1602373"},{"key":"e_1_2_6_15_2","first-page":"49","article-title":"Insulin\u2010like growth factor system in patients with HIV infection","volume":"22","author":"Mynarcik DC","year":"1999","journal-title":"Effect of exogenous growth hormone administration"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-15-1-80"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-0192"},{"key":"e_1_2_6_18_2","first-page":"104","article-title":"Systematic review","volume":"146","author":"Liu H","year":"2007","journal-title":"The safety and efficacy of growth hormone in the healthy elderly"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-8-199604150-00002"},{"key":"e_1_2_6_20_2","first-page":"2282","article-title":"Growth hormone and sex steroid administration in healthy aged women and men","volume":"288","author":"Blackman MR","year":"2002","journal-title":"A randomized controlled trial"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2004.52529_1.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000022026"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021694"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480627"},{"key":"e_1_2_6_25_2","first-page":"429","article-title":"Cytokines, insulin\u2010like growth factor 1, sarcopenia, and mortality in very old community\u2010dwelling men and women","volume":"115","author":"Roubenoff R","year":"2003","journal-title":"The Framingham Heart Study"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm124"},{"key":"e_1_2_6_27_2","first-page":"114","article-title":"The prospective association of serum insulin\u2010like growth factor I (IGF\u2010I) and IGF\u2010binding protein\u20101 levels with all cause and cardiovascular disease mortality in older adults","volume":"89","author":"Laughlin GA","year":"2004","journal-title":"The Rancho Bernardo Study"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-23198"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2088"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-8-200310210-00007"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1631"},{"key":"e_1_2_6_32_2","first-page":"263","article-title":"The Cardiovascular Health Study","volume":"1","author":"Fried LP","year":"1991","journal-title":"Design and rationale"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/41.2.264"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/1047-2797(94)00093-9"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53214.x"},{"key":"e_1_2_6_36_2","first-page":"585","article-title":"Risk factors for 5\u2010year mortality in older adults","volume":"279","author":"Fried LP","year":"1998","journal-title":"The Cardiovascular Health Study"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116164"},{"key":"e_1_2_6_38_2","first-page":"1237","article-title":"Insulin\u2010like growth factor\u20101 and interleukin 6 predict sarcopenia in very old community\u2010living men and women","volume":"51","author":"Payette H","year":"2003","journal-title":"The Framingham Heart Study"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031349"},{"key":"e_1_2_6_40_2","first-page":"277","article-title":"Serum total IGF\u2010I, free IGF\u2010I, and IGFB\u20101 levels in an elderly population","volume":"18","author":"Janssen JA","year":"1998","journal-title":"Relation to cardiovascular risk factors and disease"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853890008995950"},{"key":"e_1_2_6_42_2","article-title":"Insulin\u2010like growth factor\u2010(IGF)\u2010axis, inflammation, and glucose intolerance among older adults","author":"Rajpathak S","journal-title":"Growth Hormone IGF Res"},{"key":"e_1_2_6_43_2","first-page":"581","article-title":"Lack of association between adipose tissue distribution and IGF\u20101 and IGFBP\u20103 in men and women","volume":"11","author":"Schoen RE","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2004.09.005"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0762"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf160"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0944"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2007.01637.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2007.01637.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:38:41Z","timestamp":1762195121000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2007.01637.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,27]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1111\/j.1532-5415.2007.01637.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01637.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,27]]}}}